The aim of our research was to define both in vivo and in vitro whether and to what extent an high-impact exercise program would affect bone cell turnover and improve the QoL in osteopenic postmenopausal women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Variation in Serum Levels of Procollagen 1 N-terminal Peptide (P1NP)
Timeframe: Baseline - Week 4
Variation in Serum Levels of Procollagen 1 N-terminal Peptide (P1NP).
Timeframe: Week 4 - Week 12
Serum Sclerotin Levels
Timeframe: Baseline - W4
Sclerostin
Timeframe: Week 4 - Week 12
Variation in Serum Carboxy-terminal Telopeptide of Collagen Type I (sCTX)
Timeframe: Baseline - Week 4
Variation of Serum Carboxy Terminal Telopeptide of Collagen Type I (sCTX)
Timeframe: Week 4 - Week 12
Variation in Circulating Osteoprogenitor Cells (OPCs)
Timeframe: Baseline - Week 4
Variation in Circulating Osteoprogenitor Cells (OPCs).
Timeframe: Week 4 - Week 12